Key facts
- This page summarizes Daniel A. Macuga's Form 4/A filing for USANA HEALTH SCIENCES INC (USNA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 06 May 2024, 17:31.
Daniel A. Macuga - 02 May 2024 Form 4/A Insider Report for USANA HEALTH SCIENCES INC (USNA)
- Reporting relationship
- CHIEF COMMUNICATIONS OFFICER
- Issuer ticker
- USNA
- Reported as of
- 02 May 2024
- Net transaction value
- -$178,717
- SEC form
- 4/A
- Accepted by SEC
- 06 May 2024, 17:31:42 UTC
- Original report date
- 02 May 2024
- Prior SEC filing
- 04 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua Foukas, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Daniel A. Macuga filed Form 4/A for USANA HEALTH SCIENCES INC (USNA) on 06 May 2024.
Change
- Previous filing in this sequence was filed on 04 Mar 2024.
- Current net transaction value: -$178,717.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
USNA
transaction
Common Stock
Sale
- Transaction value
- $178,717
- Shares
- -3,791
- Change %
- -100%
- Price
- $47.14
- Shares after
- 0
- Date
- 02 May 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Daniel A. Macuga is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Weighted average price $47.1424. Price range in multiple transactions was $47.0709 to $47.31 inclusively.
SEC remarks
The Form 4 filed 5/2/2024 is being amended to reflect that the reporting individual is no longer subject to Section 16 reporting.